Skip Navigation
Skip to contents

대한신장학회

My KSN 메뉴 열기

간행물 검색
Rapid Kidney Function Decline Predicts Mortality in Compensated Cirrhosis: A Longitudinal Cohort Study
Wankawee Jeerangsapasuk
2026 ; 2026(1):
    rapid kidney function decline, compensated cirrhosis, mortality, hepatic encephalopathy
논문분류 :
춘계학술대회 초록집
Objectives: Kidney dysfunction in cirrhosis is strongly associated with adverse short-term complications; however, its long-term prognosis and clinical predictors remain underinvestigated. This study aimed to evaluate the long-term outcomes of rapid kidney function decline—defined as a reduction of >5 mL/min/1.73 m² per year—and to identify its clinical determinants in patients with compensated cirrhosis. Methods: We conducted a retrospective cohort study of patients with Child–Pugh class A cirrhosis who attended Thammasat University Hospital between 2016 and 2025. Patients with Child–Pugh class B or C cirrhosis were excluded. The primary outcome was all-cause mortality, analyzed using Cox proportional hazards models. Secondary outcomes included hospitalization, hepatic encephalopathy (HE), spontaneous bacterial peritonitis (SBP), sepsis, and heart failure (HF). Clinical predictors of rapid kidney function decline were assessed using multivariable logistic regression. The median follow-up duration was 8.4 years. Results: Among 329 patients (mean age 62.6 years; 60% male), 71 (21.5%) experienced rapid kidney function decline. These patients had a markedly higher risk of all-cause mortality (adjusted hazard ratio [HR] 9.25; 95% CI 4.62–18.51; p < 0.001), as well as higher risks of sepsis-related hospitalization (adjusted HR 3.65; 95% CI 1.75–7.62) and hepatic encephalopathy (adjusted HR 13.08; 95% CI 2.03–84.04). Multivariable logistic regression identified ascites (adjusted OR 5.73), diabetes mellitus (adjusted OR 3.30), furosemide use (adjusted OR 3.37), and prior hospitalization (adjusted OR 2.46) as independent clinical predictors of rapid kidney function decline. Conclusion: Rapid kidney function decline is a strong predictor of mortality in patients with compensated cirrhosis. Ascites, diabetes mellitus, furosemide use, and prior hospitalization are key clinical predictors.
위로가기

(06022) 서울시 강남구 압구정로 30길 23 미승빌딩 301호

Copyright© 대한신장학회. All rights reserved.